Back to top

BioCryst (BCRX) Receives a Buy from Wedbush

In a report released today, Laura Chico from Wedbush maintained a Buy rating on BioCryst, with a price target of $21.00. Chico covers the Healthcar...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

BioCryst Pharmaceuticals, Inc. (BCRX)